Lazertinib in Pretreated Epidermal Growth Factor Receptor T790M-Mutated Advanced Non-small Cell Lung Cancer: A Real-World Multicenter Study

被引：0
|
作者：
Ahn, B-C. [1 ,2 ]
Kim, H. [2 ]
Lee, J. [2 ]
Lee, J. B. [2 ]
Hong, M. -H. [2 ]
Kim, H. R. [2 ]
Cho, B. C. [2 ]
Lim, S. M. [2 ]
机构：
[1] Natl Canc Ctr, Goyang Si, South Korea
[2] Yonsei Univ, Severance Hosp, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Lazertinib; real-world data; T790M EGFR mutation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-47
引用
下载
收藏
页码：S659 / S660
页数：2
相关论文
共 50 条
  • [1] Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study
    Kim, Hyunwook
    Ahn, Beung-Chul
    Lee, Jiyun
    Lee, Jii Bum
    Hong, Min-Hee
    Kim, Hye Ryun
    Cho, Byoung Chul
    Lim, Sun Min
    LUNG CANCER, 2023, 180
  • [2] Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer
    Jean-Bernard Auliac
    Karima Saboundji
    Michel Andre
    Jeannick Madelaine
    Gilles Quere
    Philippe Masson
    Alain Vergnenegre
    Régine Lamy
    Stéphane Raymond
    Anne-Marie Chiappa
    Pierre-Alexandre Hauss
    Pierre Fournel
    Romain Corre
    Christos Chouaid
    Targeted Oncology, 2019, 14 : 307 - 314
  • [3] Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer
    Auliac, Jean-Bernard
    Saboundji, Karima
    Andre, Michel
    Madelaine, Jeannick
    Quere, Gilles
    Masson, Philippe
    Vergnenegre, Alain
    Lamy, Regine
    Raymond, Stephane
    Chiappa, Anne-Marie
    Hauss, Pierre-Alexandre
    Fournel, Pierre
    Corre, Romain
    Chouaid, Christos
    TARGETED ONCOLOGY, 2019, 14 (03) : 307 - 314
  • [4] Value of rebiopsy in advanced epidermal growth factor receptor mutated non-small cell lung cancer: Real-world data
    Conde, R. S.
    Ferreira, S. C.
    Campoa, E.
    Almodovar, M. T. A. S.
    ANNALS OF ONCOLOGY, 2020, 31 : S868 - S869
  • [5] Value of rebiopsy in advanced Epidermal Growth Factor Receptor mutated Non-Small Cell Lung Cancer: Real-world data
    Saude-Conde, R.
    Cristovao-Ferreira, S.
    Campoa, E.
    Almodovar, M. T.
    PULMONOLOGY, 2021, 27 (02): : 177 - 180
  • [6] Real-world clinical evidence of lazertinib use in acquired EGFR T790M mutated non-small cell lung cancer
    Park, Sehhoon
    Jung, Hyun Ae
    Lee, Se-Hoon
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Sun, Jong-Mu
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (09) : 1912 - +
  • [7] Real-World Study of Osimertinib in EGFR T790M-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis
    Cheema, P.
    Liu, G.
    Burkes, R.
    Owen, S.
    Yu, J.
    Hao, D.
    Rothenstein, J.
    Martel, S.
    Iqbal, M.
    Juergens, R.
    Lam, W.
    Laskin, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S803 - S803
  • [8] Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan
    Ohe, Yuichiro
    Kato, Terufumi
    Sakai, Fumikazu
    Kusumoto, Masahiko
    Endo, Masahiro
    Saito, Yoshinobu
    Baba, Tomohisa
    Sata, Masafumi
    Yamaguchi, Ou
    Sakamoto, Kei
    Sugeno, Masatoshi
    Tamura, Reiko
    Tokimoto, Toshimitsu
    Shimizu, Wataru
    Gemma, Akihiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (08) : 909 - 919
  • [9] Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer
    Lee, Jang Ho
    Kim, Eun Young
    Park, Cheol-Kyu
    Lee, Shin Yup
    Lee, Min Ki
    Yoon, Seong-Hoon
    Lee, Jeong Eun
    Lee, Sang Hoon
    Kim, Seung Joon
    Lee, Sung Yong
    Lim, Jun Hyeok
    Jang, Tae -Won
    Jang, Seung Hun
    Lee, Kye Young
    Lee, Seung Hyeun
    Yang, Sei Hoon
    Park, Dong Won
    Park, Chan Kwon
    Kang, Hye Seon
    Yeo, Chang Dong
    Choi, Chang-Min
    Lee, Jae Cheol
    CANCER RESEARCH AND TREATMENT, 2023, 55 (01): : 112 - 122
  • [10] Analysis of genomic alternations in epidermal growth factor receptor (EGFR)-T790M-mutated non-small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapy
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    Chiu, Li-Chung
    Yang, Cheng-Ta
    Kuo, Scott Chih-Hsi
    Fang, Yueh-Fu
    Wu, Chiao-En
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
12345